| 764638 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
858 TILKine-2: a novel best-in-class tumor infiltrating lymphocyte (TIL) targeting engineered IL-2 with superior pre-clinical efficacy and safety for immunotherapy of cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.858 |
Challa Sreerupa, Carnino Jonathan, Umana Andrea, Li Yuesheng, Xu Jing, Rui Lingyun, Hsieh Yao-Te |
| 764637 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
856 INBRX-106: a novel hexavalent anti-OX40 agonist for the treatment of solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.856 |
Rowell Emily, Kinkead Heather, Torretti Elisabeth, Becklund Bryan, Sulzmaier Florian, Crago William, Jones Kyle, Timmer John, Deveraux Quinn, Eckelman Brendan, Heidt Analeah |
| 764636 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
575 Dual blockade of LAG3 and TIGIT improves the treatment efficacy of a nanoparticle-mediated immunoradiation in anti-PD1 resistant lung cancer in mice |
2021-11-01 |
10.1136/jitc-2021-sitc2021.575 |
Hu Yun, Welsh James, Paris Sebastien, Bertolet Genevieve, Barsoumian Hampartsoum, Schuda Lily, He Kewen, Sezen Duygu, Wasley Mark, Mitchell Joylise, Voss Tiffany, Masrorpour Fatemeh, Jordan SILVA, Leyton Claudia Kettlun, Yang Liangpeng, Puebla-Osorio Nahum, Gandhi Saumil, Nguyen Quynh-Nhu, Cortez Angelica |
| 764635 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
749 A novel translational mouse model for assessment of human STING-targeting therapies |
2021-11-01 |
10.1136/jitc-2021-sitc2021.749 |
Sônego Fabiane, Martin Gaëlle, Beringer Audrey, Beuraud Chloé, Pappalardo Angela, Cherifi Yacine, Isnard-Petit Patricia, Thiam Kader |
| 764634 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
376 Radiation sub-study to characterize safety and tolerability of low-dose radiation in combination with afami-cel in patients with advanced cancers (NCT03132922) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.376 |
Welsh James, Ke Danxia, Osorio Nahum Puebla, Barsoumian Hampartsoum, Jackson Bryan, Bai Jane, Rosenberg Marisa, McAlpine Cheryl, Broad Robyn, Liddle Ashley, Navenot Jean-Marc, Rafail Stavros, Wang Ruoxi, Sauer Amy, Lin Quan, Danesi Hassan, Hong David |
| 764633 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
161 Anti-myeloid poly-pharmacy combined with FGFR4-targeted chimeric antigen receptors (CARs) effectively treats orthotopic rhabdomyosarcoma, modeling CAR effectiveness for solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.161 |
Sullivan Peter, Kumar Rajesh, Li Wei, Wang Lingyang, Zhang Yue, Cheuk Adam, Khan Javed, Dimitrov Dimiter, Orentas Rimas |
| 764632 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
537 OPTIMIZE-1, an open-label phase 1b/2 study assessing the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.537 |
Coaña Yago Pico de, Smith Karin Enell, Fält Anette, Flärdh Maria, Ellmark Peter, Cassier Philippe, Laethem Jean-Luc van, Carlsson Malin |
| 764631 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
85 Detection of human angiotensin-converting enzyme 2 receptor (hACE2R) on human cancer cell lines |
2021-11-01 |
10.1136/jitc-2021-sitc2021.085 |
Moudgil Tarsem, Fox Bernard, Hu Hong-Ming |
| 764630 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
56 Quantitative evaluation of the tissue micro-environment by high-resolution 17-plex immunofluorescence reveals distinct cell populations |
2021-11-01 |
10.1136/jitc-2021-sitc2021.056 |
Teplitz Kyla, Campton Daniel, McCarty Erin, Cooper Jeremy, Hellebust Anne, Allen Donald, Collins Kimberly, Lillard Kate, Kaldjian Eric, George Tad |
| 764629 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
75 Comprehensive profiling of the tumor-immune microenvironment using an augmented transcriptome |
2021-11-01 |
10.1136/jitc-2021-sitc2021.075 |
Levy Eric, Milani Pamela, Navarro Fabio, Bartha Gabor, Abbott Charles, Jacob Jose, McClory Rena, Li Robin, West John, Lyle John, Boyle Sean, Chen Richard |
